Illustrative image – not actual.
Laurus Labs has opened its new small molecule R&D centre at ICICI Knowledge Park in Hyderabad, in October to facilitates one-stop development and manufacturing service capability. It will enable innovators to accelerate its clinical and commercial phase projects. It has a total of 62 products in the R&D pipeline, either under review or under development.
The new centre, serving biopharma customers in process development work is expected to drive future growth. The facility will leverage advanced capabilities like flow chemistry, and high potent chemistry. It is also expanded capabilities at its fermentation site with the addition of a new pilot plant, allowing to further optimise capacity.
The plan for a larger fermentation capacity wlll help capitalise on the GMP manufacturing opportunity, and enable it to be a diversified contract development & manufacturing organisation (CDMO) company, meeting complex needs of its customers. This aligns to its long-term investment strategy of advancing both development expertise and building integrated large-scale manufacturing capabilities.
